Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-03 Purchase | 2021-09-07 08:25 am | EXAGEN INC. | XGN | Johnson Wendy S. Director | 1,000 | $14.02 | $14,020 | 1,000 (Direct) | View |
| 2021-07-14 Sale | 2021-07-15 5:33 pm | Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer | 111,736 | $8.5 | $949,756 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-09 Option Award | 2023-06-13 4:35 pm | N/A 2033-06-08 | EXAGEN INC. | XGN | Johnson Wendy S. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 08:34 am | N/A 2032-06-15 | EXAGEN INC. | XGN | Johnson Wendy S. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-09 6:52 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer | 111,736 | $1.97 | 111,736 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-09 6:52 pm | 2017-09-01 2028-04-04 | Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer | 111,736 | $0 | 111,736 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:38 am | N/A 2031-06-16 | EXAGEN INC. | XGN | Johnson Wendy S. Director | 9,000 | $0 | 9,000 (Direct) | View |
Ownership | 2021-04-08 5:02 pm | 2017-09-01 2028-04-04 | Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer | 0 | $0 | 257,440 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-01 4:33 pm | N/A 2030-09-30 | EXAGEN INC. | XGN | Johnson Wendy S. Director | 15,000 | $0 | 15,000 (Direct) | View |